The market for cell-free RNA isolation and extraction kits is well-developed and plays a crucial role in the acquisition of data for a variety of therapy strategies, underscoring its importance in the healthcare industry. Since it guarantees the safe and efficient use of targeted therapies, cell-free RNA is essential to the precision medicine approach. The majority of market participants in the global market for cell-free RNA isolation and extraction kits provide goods that include the kits.
Increasing investments in the RD for cell-free RNA isolation and extraction is one of the major opportunities in the global cell-free RNA isolation and extraction kits market. Several biotechnology and pharmaceutical companies are working collaboratively to adopt cell-free RNA isolation and extraction in the field of oncology, prenatal screening, and metabolic disorders.
The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032. The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers offering cell-free RNA analysis.
Impact
• The presence of major products of cell-free RNA isolation and extraction kits in regions such as North America and APAC has a major impact on the market. For instance, QIAGEN N.V. provides cell-free RNA isolation and extraction kits.
• Companies such as Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems The presence of these companies has a positive impact on the market growth.
Recent Developments in Global Cell-Free RNA Isolation and Extraction Kits Market
• In February 2022, Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems.
• In February 2019, Norgen Biotek Corp. introduced the cf-DNA / cf-RNA Preservative Tubes for long-term storage of blood. These are more suitable blood collection tubes (BCTs) as compared to other competitor’s blood collection tubes (BCTs) in the cell-free RNA market. This is the only product that keeps both cf-DNA and cf-RNA in the same tube for 30 days, allowing researchers to examine both genomics and transcriptomics.
Market Segmentation:
Segmentation 1: by Application
• Oncology
• Prenatal Screening (Preeclampsia)
• Metabolic Disorders
The oncology segment accounted for the largest share of 79.85% in the global cell-free RNA isolation and extraction kits market in 2021.
Segmentation 2: by End User
• Hospitals
• Academic Research Institutions and Laboratories
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
The academic research institutions and laboratories segment accounted for the largest share of 63.13% in the global cell-free RNA isolation and extraction kits market in FY2021.
Segmentation 3: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World
North America cell-free RNA isolation and extraction market dominated the global cell-free RNA isolation and extraction kits market and is expected to maintain its dominance over other regions throughout the forecast period 2022-2032.
Demand – Drivers and Limitations
Following are the demand drivers for the Global Cell-Free RNA Isolation and Extraction Kits Market:
• Increasing Incidence of Cancer
• Increasing Number of Cases with Prenatal Complications
• Advancement in the RNA Sequencing Technology
The market is expected to face some limitations too due to the following challenges:
• Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
• Ethical, Legal, and Social Issues Associated with Prenatal Screening
Get Free Sample Report - https://bisresearch.com/requestsample?id=1355type=download
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
The leading top segment players include cell-free RNA isolation and extraction kits manufacture in year 2021 that caters to different area of application that includes oncology, prenatal screening, and metabolic disorders.
Some of the prominent names established in this market are:
• Aline Biosciences
• Apostle Sciences
• Danagen-Bioted, SL
• F. Hoffmann-La Roche Ltd.
• JBS Science Inc.
• Norgen Biotek Corp.
• PerkinElmer, Inc.
• Promega Corporation • QIAGEN
NV
• Streck, Inc.
• Thermo Fisher Scientific Inc.
• Takara Bio Inc.
• Zymo Research Corporation
Key Questions Answered in the Report
- How is the cell-free RNA isolation and extraction kits
- market revolutionizing oncology, prenatal screening, and metabolic disorders' landscapes?
- What are the major market drivers, challenges, and opportunities in the global cell-free RNA isolation and extraction kits market?
- What are the underlying structures resulting in the emerging trends within the cell-free RNA isolation and extraction kits market?
- What are the key development strategies that are being implemented by major players to sustain themselves in the market?
- What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free RNA products and services?
- How is each segment of the market expected to grow during the forecast period 2022-2032, and what revenue is anticipated to be generated by each of the segments? Following are the segments:
- Application (Oncology, Prenatal Screening, and Metabolic Disorders)
- End User (Hospitals, Academic Research Institutions and Laboratories, Pharmaceutical and Biotechnology Companies, and Diagnostic Laboratories)
- Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
- What are the growth opportunities for the cell-free RNA companies in the region of their operation?
- Who are the leading players with significant offerings in the global cell-free RNA isolation and extraction kits market?
- Which companies are anticipated to be highly disruptive in the future and why?
USP of this report
• Extensive competitive benchmarking of the top 13 players has been done to offer a holistic view of the global cell-free RNA isolation and extraction kits market landscape
• Market ranking analysis based on product portfolio, recent developments, and regional spread
• Investment landscape including product adoption scenario, funding, and patent analysis
BIS Related Studies
Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis
